Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

BEAM

Beam Therapeutics (BEAM)

Beam Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:BEAM
일자시간출처헤드라인심볼기업
2022/08/0905:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BEAMBeam Therapeutics Inc
2022/08/0221:30GlobeNewswire Inc.Beam Therapeutics to Participate in the 2022 Wedbush PacGrow Virtual Healthcare ConferenceNASDAQ:BEAMBeam Therapeutics Inc
2022/08/0120:22Dow Jones NewsBeam Therapeutics Shares Fall Premarket as FDA Puts Study on HoldNASDAQ:BEAMBeam Therapeutics Inc
2022/08/0119:30GlobeNewswire Inc.Beam Therapeutics Announces FDA Clinical Hold on BEAM-201 IND ApplicationNASDAQ:BEAMBeam Therapeutics Inc
2022/07/1504:56Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BEAMBeam Therapeutics Inc
2022/06/2719:30GlobeNewswire Inc.Beam Therapeutics to Present First Research Highlighting Approach to Develop Non-Genotoxic Conditioning Regimens for Patients with Sickle Cell Disease Ahead of Autologous TransplantNASDAQ:BEAMBeam Therapeutics Inc
2022/06/1105:57Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BEAMBeam Therapeutics Inc
2022/06/0319:42GlobeNewswire Inc.Beam Therapeutics to Participate in the 2022 Jefferies Healthcare ConferenceNASDAQ:BEAMBeam Therapeutics Inc
2022/05/0920:34Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BEAMBeam Therapeutics Inc
2022/05/0920:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BEAMBeam Therapeutics Inc
2022/05/0919:30GlobeNewswire Inc.Beam Therapeutics Announces Pipeline and Business Highlights and Reports First Quarter 2022 Financial ResultsNASDAQ:BEAMBeam Therapeutics Inc
2022/05/0419:30GlobeNewswire Inc.Beam Therapeutics to Participate in Upcoming May Investor ConferencesNASDAQ:BEAMBeam Therapeutics Inc
2022/05/0305:30GlobeNewswire Inc.Beam Therapeutics to Present New Preclinical Data from Base Editing Pipeline at ASGCT 25th Annual MeetingNASDAQ:BEAMBeam Therapeutics Inc
2022/04/2305:25Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BEAMBeam Therapeutics Inc
2022/04/1506:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BEAMBeam Therapeutics Inc
2022/03/2519:30GlobeNewswire Inc.Beam Therapeutics to Participate in the Guggenheim Genomic Medicines and Rare Disease ConferenceNASDAQ:BEAMBeam Therapeutics Inc
2022/03/0820:30GlobeNewswire Inc.Beam Therapeutics to Participate in the Barclays 2022 Global Healthcare ConferenceNASDAQ:BEAMBeam Therapeutics Inc
2022/02/2822:32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BEAMBeam Therapeutics Inc
2022/02/2821:33Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BEAMBeam Therapeutics Inc
2022/02/2821:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BEAMBeam Therapeutics Inc
2022/02/2820:30GlobeNewswire Inc.Beam Therapeutics Reports Pipeline and Business Highlights, Planned 2022 Milestones and Fourth Quarter and Full Year 2021 Financial ResultsNASDAQ:BEAMBeam Therapeutics Inc
2022/02/1508:19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BEAMBeam Therapeutics Inc
2022/02/1005:34Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BEAMBeam Therapeutics Inc
2022/02/1004:05Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BEAMBeam Therapeutics Inc
2022/02/0923:13Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BEAMBeam Therapeutics Inc
2022/02/0920:30GlobeNewswire Inc.Beam Therapeutics to Present at the SVB Leerink 11th Annual Global Healthcare ConferenceNASDAQ:BEAMBeam Therapeutics Inc
2022/02/0506:34Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BEAMBeam Therapeutics Inc
2022/02/0308:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BEAMBeam Therapeutics Inc
2022/02/0308:00Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:BEAMBeam Therapeutics Inc
2022/02/0308:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BEAMBeam Therapeutics Inc
 검색 관련기사 보기:NASDAQ:BEAM